title: Who should be taking aspirin to prevent coronary events?
abstract: The decision to prescribe aspirin to prevent a coronary event is not straightforward, and requires physicians to balance the risk of a coronary event with the risk of adverse events from aspirin. Although evidence-based medicine shows the way, it does not answer all the questions, especially for patients at intermediate risk.
authors.affiliation: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA. lauerm@ccf.org
authors.forename: Michael S
authors.initials: MS
authors.lastname: Lauer
mesh_terms: D000368:Aged; D000465:Algorithms; D001241:Aspirin / Q000627:therapeutic use*; D000075202:Contraindications; D003327:Coronary Disease / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010809:Physical Fitness; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin